No Picture
News

Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report fourth quarter and full […]

News

Fresh Start Surgical Gifts Hosts 32nd Annual Celebrity Golf Classic Hosted by Alfonso Ribeiro, Transforming Lives One Swing at a Time

SAN DIEGO, Feb. 29, 2024 /PRNewswire/ — Nationally recognized nonprofit, Fresh Start Surgical Gifts is teeing up for its 32nd Annual San Diego Celebrity Golf Classic, celebrating another year of transforming lives. The event will […]

News

Avidity Biosciences Honors Rare Disease Day®

SAN DIEGO, Feb. 29, 2024 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced its support for Rare […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
News

Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases

SAN DIEGO–(BUSINESS WIRE)–Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases Click here to view original post Click Here to Publish/Feature Your Company or Product News […]

ADVERTISEMENT — Advertise With Biotech Networks
News

‘Gene of Prejudice’ Demystifies Autism

Individuals with Williams syndrome have a gregarious “cocktail party” personality, while those with the opposite genetic alteration, in contrast, tend to have autistic traits and are prone to struggle socially. Research from UC San Diego […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
News

Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024

SAN DIEGO, Feb. 28, 2024 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webcast on Tuesday, March 12, 2024, at […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the fourth quarter and full year ended December 31, 2023. “2023 was a transformational year for Acadia that positioned us for continued […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium

BRIDGEWATER, N.J., Feb. 27, 2024 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced […]

No Picture
News

Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy

SAN DIEGO, Feb. 27, 2024 (GLOBE NEWSWIRE) — – Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, announced today that the Company […]

News

With a Two-Year Revenue Growth of 530%, Cymbiotika Ranks No. 31 on Inc. Magazine’s List of the Pacific Region’s Fastest-Growing Private Companies

Companies on the 2024 Inc. 5000 Regionals: Pacific list had an average growth rate of 162.77 percent. SAN DIEGO, Feb. 27, 2024 /PRNewswire/ — Inc. magazine today revealed that Cymbiotika, a leading lifestyle and wellness […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Drug Development

STAT+: Obesity drug from Viking Therapeutics hits target in Phase 2 study, raising hopes for a competitor to existing medicines

An obesity drug from Viking Therapeutics succeeded in a Phase 2 study, helping patients lose nearly 15% of weight and further fueling the competition in the obesity market.  Click here to view original post Click […]

News

Having Self-Control Leads to Power

New research from the UC San Diego Rady School of Management and Texas A&M University finds that having self-control is often what leads to power. Click here to view original post Click Here to Publish/Feature […]